Albumin recovery time may forecast surgical outcomes

NCT ID NCT07263061

Recruiting now Knowledge-focused Sponsor: Institute of Liver and Biliary Sciences, India Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 1,000 patients undergoing major liver, pancreas, or bile duct surgery to see if the time it takes for their albumin levels to return to normal can predict complications and length of hospital stay. Albumin is a protein that drops after surgery due to inflammation. Researchers will measure how quickly it rises without extra albumin supplements. The goal is to find a simple, early marker of recovery. No new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify patients at higher risk of complications after major liver or pancreas surgery, allowing for earlier support.
What could go wrong: This is an observational study, not a treatment trial. It only looks for patterns, so it cannot prove cause and effect. Results may not apply to all surgery types or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILE DUCT DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bile duct disorder Digestive System Diseases hepatobiliary disorder pancreas disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILE DUCT DISEASES HEPATOBILIARY DISEASE PANCREAS DISEASE

Contacts and locations

Locations

ILBS
RECRUITING

New Delhi, National Capital Territory of Delhi, 110070, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.